Ruiting Lin Ruilian Chen Zhiqiang Chen Leihao Hu Wei Guo Zexin Zhang Lizhu Lin Hanrui Chen
10.3389/fonc.2021.731572
Front Oncol
2021 Sep 2;11:731572.
l861q mutation compound mutation epidermal growth factor receptor non-small-cell lung cancer osimertinib tyrosine kinase inhibitor uncommon mutation
CC BY
https://pubmed.ncbi.nlm.nih.gov/34540698/
Case Reports
PMC8445031
34540698
Efficacy of Osimertinib in NSCLC Harboring Uncommon EGFR L861Q and Concurrent Mutations: Case Report and Literature Review
2021